BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 209 filers reported holding BRIDGEBIO PHARMA INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $46,424 | -85.8% | 2,800 | -91.5% | 0.00% | -88.0% |
| Q3 2022 | $327,000 | +1823.5% | 32,995 | +1577.4% | 0.02% | +1150.0% |
| Q2 2022 | $17,000 | -59.5% | 1,967 | -53.2% | 0.00% | -50.0% |
| Q1 2022 | $42,000 | +281.8% | 4,200 | +500.0% | 0.00% | +300.0% |
| Q4 2021 | $11,000 | -98.0% | 700 | -93.9% | 0.00% | -97.5% |
| Q3 2021 | $541,000 | +286.4% | 11,558 | +402.5% | 0.04% | +263.6% |
| Q2 2021 | $140,000 | +79.5% | 2,300 | +109.1% | 0.01% | +37.5% |
| Q4 2020 | $78,000 | +420.0% | 1,100 | +175.0% | 0.01% | +300.0% |
| Q3 2020 | $15,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $373,797,000 | 67.28% |
| Darwin Global Management, Ltd. | 2,090,149 | $128,753,000 | 25.21% |
| Affinity Asset Advisors, LLC | 577,500 | $35,574,000 | 12.08% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $1,913,356,000 | 9.64% |
| Perceptive Advisors | 7,756,928 | $477,827,000 | 6.04% |
| Opaleye Management Inc. | 583,767 | $35,960,000 | 5.28% |
| MIZUHO MARKETS AMERICAS LLC | 171,923 | $10,590,000 | 4.93% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $1,639,853,000 | 4.88% |
| Fernwood Investment Management, LLC | 151,085 | $9,307,000 | 3.42% |
| HHLR ADVISORS, LTD. | 5,362,014 | $330,300,000 | 3.26% |